510(k) Report

510(k) · Cleared

Cleared

Revogene

K243922510(k) TraditionalCleared Mar 20, 202590-day reviewClass II21 CFR 862.2570

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Meridian Bioscience, Inc. · OOI Real Time Nucleic Acid Amplification System

Cleared on Mar 20, 2025 as substantially equivalent to K222779 (Meridian Bioscience, Inc., 2023) after a 90-day review. Its family tree reaches back 3 generations to 2017.

Decided
Mar 20, 2025
Review
90 days
Class
Class II
Product code
OOI
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K170558 (2017). No later device cites it as a predicate yet.

  1. Root · 3 generations backK170558 revogeneGenepoc, Inc. · 2017 · Recalled
  2. 2 generations backK220480 RevogeneMeridian Bioscience, Inc. · 2022
  3. 1 generation backK222779 RevogeneMeridian Bioscience, Inc. · 2023
  4. This deviceK243922 RevogeneMeridian Bioscience, Inc. · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K170558revogeneGenepoc, Inc.20172
−2K220480RevogeneMeridian Bioscience, Inc.2022—
−1K222779RevogeneMeridian Bioscience, Inc.2023—
0 (this device)K243922RevogeneMeridian Bioscience, Inc.2025—
FIG. 1 — Lineage of K243922, 2017–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OOI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OOI device

  1. #1 K222779 Revogenescore 8.0 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K222779Revogene
Summary page 4
…y (75) D. Purpose of Submission This 510(k) Premarket Notification is meant to obtain FDA clearance for a modified version of the Revogene instrument cleared under K222779. A cooling system to reduce the temperature around the photomultiplier tube (PMT) and associated firmware updates are added t…
Meridian Bioscience, Inc.2023—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 8 years and passes through 2 companies; a new generation was cleared every 2.1 years on median.
  • 1 of the 3 ancestors has a recall of any class.

How does its category compare?

All OOI devices

OOI Real Time Nucleic Acid Amplification System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · OOI

1in 2025

2010: 32012: 12013: 12014: 12015: 22016: 22017: 12022: 12023: 12025: 1
2007high 3 (2010) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OOI

249in 2010

2010: 249 days median
2007high 249 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OOI

1in 2024

2010: 12011: 22013: 12021: 42022: 42023: 12024: 1
2007high 4 (2021) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OOI

524in 2025

2011: 52012: 32013: 12014: 52015: 12016: 32019: 22020: 1342021: 3242022: 8742023: 2202024: 3272025: 524
2007high 874 (2022) · low 0 (2007)2025

MAUDE reports naming product code OOI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
2010324910
20110—25
20121—03
20131—11
20141—05
20152—01
20162—03
20171—00
20180—00
20190—02
20200—0134
20210—4324
20221—4874
20231—1220
20240—1327
20251—0524
20260—0—

What is it indicated for?

The Revogene® instrument is intended for in vitro diagnostic (IVD) use in performing nucleic acid testing of specific IVD assays in clinical laboratories. Revogene is capable of automated lysis and dilution of samples originating from various clinical specimen types. Revogene performs automated amplification and detection of target nucleic acid sequences by fluorescence-based real-time PCR.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K243922: Revogene.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K243922

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026